首页> 外文期刊>Journal of pediatric hematology/oncology: Official journal of the American Society of Pediatric Hematology/Oncology >Haploidentical Bone Marrow Transplantation With Clofarabine and Busulfan Conditioning for a Child With Multiple Recurrent Acute Lymphoblastic Leukemia
【24h】

Haploidentical Bone Marrow Transplantation With Clofarabine and Busulfan Conditioning for a Child With Multiple Recurrent Acute Lymphoblastic Leukemia

机译:单倍体骨髓移植联合氯法拉滨和环丁砜治疗多发性急性淋巴细胞白血病的儿童

获取原文
获取原文并翻译 | 示例
           

摘要

Outcome of children with acute lymphoblastic leukemia (ALL) has improved over the years, but not for those with multiple recurrences because of high therapy resistance and heavily pretreated history that potentially cause physical damages. We describe the case of an 11-year-old boy with a third relapse of ALL and a history of 2 allogeneic bone marrow transplantations. He was successfully treated with clofarabine combination chemotherapy and achieved a fourth remission at 16 months following haploidentical bone marrow transplantation with conditioning regimen of clofarabine and busulfan. Clofarabine/busulfan conditioning might be a preferable option for children with multiple recurrent ALL, and warrants further investigation.
机译:多年来,急性淋巴细胞白血病(ALL)儿童的结局已有所改善,但对于多发性复发的儿童却没有改善,因为其高治疗抗性和大量治疗前病史可能会造成身体伤害。我们描述了一个11岁男孩的案例,其中ALL发生了第三次复发,并且有2次同种异体骨髓移植的历史。他已成功接受氯法拉滨联合化疗的治疗,并在单倍体骨髓移植后用氯法拉滨和白消安的调理方案获得了16个月的第四次缓解。对于多发性ALL复发的儿童,氯法拉滨/环丁砜治疗可能是更可取的选择,值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号